Psychopharmacology for Children and Adolescents. WHAT PSYCHOLOGISTS AND COUNSELORS WHO WORK WITH KIDS SHOULD KNOW. FDA Approval. Resource for Pediatric FDA medication approval. www.fda.gov/cder/drugsatfda. Trends .
Psychopharmacology for Children and Adolescents
WHAT PSYCHOLOGISTS AND COUNSELORS WHO WORK WITH KIDS SHOULD KNOW.
Augmentation for anxiety
Goodwin F, Jamison K. Manic Depression. New York: Oxford University Press; 1990.
FDA approved ABILIFY® (aripiprazole) for the acute treatment of manic and mixed episodes, maintenance treatment of manic or mixed episodes, and as add-on treatment to lithium or valproate, associated with Bipolar I Disorder, with or without psychotic features, and schizophrenia in pediatric patients (10 to 17 years old).
No blood tests
Once a day dosing
FDA approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.
Some reports of mania induction